麻醉和呼吸设备市场按产品类型、应用、最终用户、技术、患者年龄层、便携性、分销管道、动力来源、模式和价格分布——2025-2032年全球预测

预计到 2032 年，麻醉和呼吸设备市场规模将达到 662.3 亿美元，复合年增长率为 6.41%。

主要市场统计数据
基准年 2024	402.7亿美元
预计年份：2025年	428.6亿美元
预测年份：2032年	662.3亿美元
复合年增长率 (%)	6.41%

全面介绍影响麻醉和呼吸设备决策的营运、临床和商业因素。

麻醉和呼吸设备市场格局受临床优先事项、技术创新和不断变化的医疗服务模式的共同影响，因此，经营团队和临床领导者需要清晰的指导才能应对。麻醉仪器、持续性正压呼吸器（CPAP）系统、雾化器、氧气浓缩机和人工呼吸器等设备构成了手术全期护理、加护治疗、慢性病管理和家庭呼吸支持的基础。每种设备类别内部都存在细微的配置差异。例如，麻醉仪器分为携带式和固定式，人工呼吸器分为有创和非侵入性两种平台，每种平台都有不同的操作模式。这些差异至关重要，因为它们会影响医疗系统和门诊护理机构的采购标准、培训需求和生命週期管理策略。

数位转型、分散式医疗模式和供应链韧性如何重新定义医疗设备组合的竞争优势和临床价值

麻醉和呼吸设备领域正经历着变革性的转变，其驱动力包括技术融合、医疗服务分散化以及患者对以患者为中心的服务日益增长的需求。在技​​术层面，传统上以机械功能为核心的设备正在迅速整合数位感测、云端远端监控和嵌入式分析等技术。这种转变增强了远端监控能力，改善了警报管理，并支援了预测性维护，同时也对网路安全和资料管治提出了新的要求。因此，除了可靠性和临床性能等传统指标外，采购决策也越来越重视软体生态系统、更新管道以及与电子健康记录 (EHR) 的整合。

本文对2025年关税调整如何重塑医疗设备价值链的筹资策略、采购重点和营运弹性进行了务实的分析。

关税的实施将改变美国医疗保健生态系统中製造商、经销商和买家的营运决策。关税变化将影响筹资策略、成本结构和采购决策，而其在2025年的累积影响将取决于企业在营运和商业性的应对措施。当关税增加投入成本或成品进口价格时，製造商通常会重新评估与供应商的关係，并可能加快本地化生产或近岸外包以降低风险。虽然这些调整可以缩短交货时间并提高供应连续性，但它们需要资本投资和长期规划，这可能会压缩短期利润率。

透过对产品类型、临床应用、终端用户环境和技术选择进行深度细分，帮助确定产品开发和商业策略的优先顺序。

观点揭示了产品特性、临床应用、终端使用者环境和技术选择如何交织，形成差异化的需求管道。产品类型（麻醉仪器、CPAP 设备、雾化器、氧气浓缩机和人工呼吸器）的区分是本分析的基础，而携带式与固定式麻醉仪器、侵入性与非侵入性人工呼吸器架构等子类别则决定了产品的市场应用情境和临床训练需求。在 CPAP 平台中，自动调节系统和固定压力系统在患者依从性和服务需求方面存在差异。同时，雾化器技术（喷射式、网式、超音波等）对雾化效果、维护和耗材的影响也各不相同。

区域差异与通用挑战：影响美洲、欧洲、中东、非洲与亚太地区商业化与监管方式的因素

区域趋势对设备设计、报销通路和分销策略有显着影响，美洲、欧洲、中东和非洲以及亚太地区的需求各不相同。在美洲，医疗系统特别重视与电子健康记录系统的互通性、完善的售后服务网络以及经证实的临床和经济价值。在这种环境下，能够展示临床疗效并提供可扩展服务基础设施以支援医院和居家照护机构的供应商将更具优势。

一项结合数位整合、服务创新和模组化产品架构的竞争性企业策略，旨在确保可持续的差异化优势。

麻醉和呼吸设备领域的主要企业正在调整研发投入、併购活动和服务创新，以确保可持续的差异化优势。市场领导正在加速将数位健康功能（例如演算法监测、远距离诊断和无线软体更新）整合到固定和携带式平台中，从而增强临床决策支持，并透过预测性维护降低整体拥有成本。随着企业寻求检验疗效并展现对医疗保健系统的长期价值，与软体供应商、云端平台和临床研究网路的策略合作也不断增加。

针对产品蓝图、商业模式和供应链韧性，提供切实可行的建议，将策略洞察转化为营运优势。

产业领导者若想将洞察转化为竞争优势，应优先进行一系列协作行动，以解决产品、商业和营运等各个面向的问题。首先，透过与临床医生和居家照护护理人员共同设计产品功能，使产品开发与实际临床工作流程相契合，确保设备的易用性、维护流程和连接性能够满足分散式医疗服务的需求。其次，投资建造可扩展的服务培训基础设施，使其能够部署在任何场所，包括医院、门诊手术中心和家庭环境。这包括远端支援平台、临床人员认证项目以及标准化的维护网络，从而减少停机时间并简化采购决策。

我们采用方法严谨的策略，结合关键相关人员对话、监管审查和情境分析，以确保其实际相关性和检验。

本分析的调查方法结合了严谨的一手研究和系统的二手分析，以确保研究结果的稳健性和实用性。一手研究活动包括与加护病房、手术室和居家医疗机构的临床负责人、医院和门诊手术中心的采购主管以及医疗设备和分销机构的高级产品和战略主管进行深度访谈和结构化对话。这些对话提供了关于临床需求、采购决策依据以及与器械实施和维护相关的营运挑战的定性见解。

整合策略要务和实用洞见，指南您整个设备组合的投资重点、商业规划和营运韧性。

总而言之，在数位整合、医疗服务分散化以及对供应链韧性的重新重视等因素的驱动下，麻醉和呼吸设备领域正经历着显着的变革时期。设备差异化越来越依赖临床表现、软体支援服务以及灵活的商业模式，以满足医院、门诊中心和家庭等不同环境的需求。关税调整和地缘政治趋势正在促使企业重新评估筹资策略，并加速对区域能力的投资。同时，市场区隔洞察也凸显了基于使用模式、便携性性、患者年龄层和价格分布进行产品客製化的需求。

目录

第一章：序言

第二章调查方法

第三章执行摘要

第四章 市场概览

第五章 市场洞察

• 将用于预测患者管理的人工智慧演算法整合到人工呼吸器控制系统中
• 扩大用于居家医疗和远端监测整合的非侵入性通气设备
• 开发具有封闭回路型药物传输和即时病患监测的新一代麻醉仪器
• 采用具备无线连线功能的携带式呼吸设备进行远端患者管理与数据分析
• 引入一次性麻醉管路，以降低感染风险并提高手术室週转效率
• 在麻醉工作站中引入先进感测器，以便早期检测患者低氧血症和血流动力学不稳定。
• 在加护治疗环境中，高流量氧气鼻管治疗系统的需求正在迅速增长，以帮助控制呼吸窘迫。
• 云端基础呼吸器资料平台在集中监控和预测性维护方面的应用日益广泛
• 超音波雾化器技术在慢性呼吸系统疾病治疗中针对气溶胶药物传递的进展
• 开发内建生物感测器的智慧气管插管，用于连续监测气道压力和生物标记

第六章美国关税的累积影响，2025年

第七章 人工智慧的累积影响，2025年

8. 按产品类型分類的麻醉和呼吸设备市场

• 麻醉仪器
  • 可携式的
  • 固定式
• CPAP设备
  • 自动调节
  • 固定压力
• 喷雾器
  • 喷射式雾化器
  • 网状雾化器
  • 超音波雾化器
• 氧气浓缩机
  • 可携式的
  • 固定式
• 人工呼吸器
  • 侵入性
    • 混合模式
    • 压力控制
    • 自发呼吸模式
    • 容量控制
  • 非侵入性
    • 双水平正压通气
    • 持续性气道正压通气

9. 按应用分類的麻醉和呼吸设备市场

• 救护车运输
• 居家医疗
• 加护治疗
  • 成人
  • 新生
  • 儿童
• 手术室

第十章 按最终使用者分類的麻醉和呼吸设备市场

• 门诊手术中心
• 诊所
• 居家医疗环境
• 医院

第十一章 按技术分類的麻醉和呼吸设备市场

• 侵入性
  • 混合模式
  • 压力控制
  • 自发呼吸模式
  • 容量控制
• 非侵入性
  • 双水平正压通气
  • 持续性气道正压通气

第十二章：依病患年龄层分類的麻醉和呼吸设备市场

• 成人
• 新生
• 标准

13. 按便携性分類的麻醉和呼吸设备市场

• 可携式的
• 固定式

第十四章 按分销管道分類的麻醉和呼吸设备市场

• 直销
• 批发商
• 在线的

第十五章 按动力来源的麻醉和呼吸设备市场

• 电池供电
• 电动式的
• 手动输入
• 气动

第十六章 麻醉及呼吸设备市场（依模式划分）

• 混合模式
• 压力控制
• 自发呼吸模式
• 容量控制

第十七章：麻醉和呼吸设备市场（依价格分布）

• 低价
• 高价
• 标准价格

第十八章：麻醉和呼吸设备市场（按地区划分）

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十九章 按组别分類的麻醉和呼吸设备市场

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第20章 各国麻醉及呼吸设备市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第21章 竞争情势

• 2024年市占率分析
• FPNV定位矩阵，2024
• 竞争分析
  • GE HealthCare Technologies Inc.
  • Koninklijke Philips NV
  • Dragerwerk AG & Co. KGaA
  • Medtronic plc
  • Fisher & Paykel Healthcare Corporation Limited
  • Hamilton Medical AG
  • Smiths Group plc
  • Teleflex Incorporated
  • B. Braun Melsungen AG
  • ResMed Inc.

The Anesthesia & Respiratory Devices Market is projected to grow by USD 66.23 billion at a CAGR of 6.41% by 2032.

KEY MARKET STATISTICS
Base Year [2024]	USD 40.27 billion
Estimated Year [2025]	USD 42.86 billion
Forecast Year [2032]	USD 66.23 billion
CAGR (%)	6.41%

A comprehensive contextual introduction to the operational, clinical, and commercial contours shaping anesthesia and respiratory device decision making

The anesthesia and respiratory device landscape is defined by converging clinical priorities, technological innovation, and shifts in care delivery that demand a clear, contextual introduction for executives and clinical leaders. Devices such as anesthesia machines, CPAP systems, nebulizers, oxygen concentrators, and ventilators serve as the backbone of perioperative, critical care, chronic disease management, and home-based respiratory support. Each device class encompasses nuanced configurations, for example anesthesia machines split into portable and stationary formats and ventilators available as invasive and noninvasive platforms with distinct operating modes. These distinctions matter because they drive procurement criteria, training needs, and lifecycle management strategies across health systems and ambulatory settings.

Beyond device taxonomy, an effective introduction must highlight how emergent pressures-aging populations, rising chronic respiratory disease prevalence, constrained acute care capacity, and an emphasis on hospital-at-home models-are reshaping demand patterns. Technology adoption is accelerating, with digital monitoring, telehealth integration, and smarter user interfaces increasingly expected across both stationary and portable products. Regulatory frameworks and reimbursement policies are evolving in tandem, emphasizing safety, interoperability, and outcomes-based performance metrics. Consequently, manufacturers and providers must align product road maps and service models with clinical pathways and supply chain realities to remain relevant.

This section establishes the foundational context for a detailed analysis by clarifying device categories, clinical applications, and the stakeholder ecosystem. It sets the stage for subsequent sections, which examine systemic shifts, tariff impacts, segmentation-based insights, regional dynamics, corporate strategies, and recommendations tailored to leaders intent on translating insight into measurable action.

How digital transformation, decentralized care models, and supply chain resilience are redefining competitive advantage and clinical value in device portfolios

The anesthesia and respiratory device sector is experiencing transformative shifts driven by technology fusion, care decentralization, and heightened expectations for patient-centric services. On the technology front, devices once defined by mechanical functionality are rapidly incorporating digital sensing, cloud-enabled telemonitoring, and embedded analytics. This transition enhances remote monitoring capabilities, improves alarm management, and supports predictive maintenance, while also creating new requirements for cybersecurity and data governance. As a result, procurement decisions increasingly weigh software ecosystems, update pathways, and integration with electronic health records alongside traditional metrics of reliability and clinical performance.

Concurrently, care delivery models are decentralizing. Hospital-at-home initiatives, expanded outpatient surgical centers, and home-based chronic respiratory management are shifting demand toward portable, battery-powered, and easy-to-operate devices. These mobility-driven preferences place a premium on intuitive user interfaces, maintenance simplicity, and logistics solutions that support device rotation and servicing across dispersed settings. Moreover, clinicians and health system leaders are placing greater emphasis on patient experience and adherence, particularly for long-term therapies like CPAP and oxygen concentrators, which prompts product developers to invest in comfort features and behavioral engagement tools.

Supply chain resilience has emerged as a strategic priority following recent global disruptions, accelerating efforts to diversify suppliers, regionalize manufacturing, and build redundancy in critical components. Regulatory regimes are adapting to novel device modalities and software-as-medical-device constructs, prompting manufacturers to adopt more rigorous post-market surveillance and evidence-generation plans. Taken together, these forces are reshaping competitive advantages across the ecosystem, privileging organizations that can deliver integrated clinical outcomes, service excellence, and flexible deployment models.

Practical analysis of how 2025 tariff adjustments are reshaping sourcing strategies, procurement priorities, and operational agility across the device value chain

The imposition of tariffs alters the operating calculus for manufacturers, distributors, and purchasers within the United States healthcare ecosystem. Tariff changes influence procurement strategies, cost structures, and sourcing decisions, and their cumulative effect in 2025 will be shaped by how companies respond operationally and commercially. When tariffs increase input costs or finished-goods import prices, manufacturers commonly reassess supplier relationships and may accelerate regional manufacturing or nearshoring to mitigate exposure. These adjustments can reduce delivery lead times and improve supply continuity, but they also require capital investment and longer-run planning that can compress short-term margins.

For health systems and other end users, tariff-driven price pressures may translate into more rigorous procurement evaluations and heightened interest in total cost of ownership analyses that include maintenance, consumables, and device uptime. Procurement teams may prioritize devices with lower lifecycle service costs or favor vendors that offer bundled maintenance and consumable agreements designed to stabilize expenses. In parallel, distributors and online channels may play a larger role as intermediaries that absorb some operational variability by leveraging scale and flexible inventory strategies.

Regulatory compliance and documentation burdens also shift along with tariff changes, as cross-border movement of components often necessitates additional customs reporting and classification reviews. Smaller OEMs and start-ups can be disproportionately affected due to limited resources to reconfigure supply chains quickly. Conversely, larger companies with diversified manufacturing footprints may gain competitive advantage by reallocating production and preserving pricing stability. Across the value chain, strategic responses center on operational agility, contract renegotiation, and targeted investment in regional capacity to limit the operational and financial friction introduced by tariff interventions.

Deep segmentation insights linking product types, clinical applications, end-user settings, and technology choices to prioritize product development and commercial strategies

A segmentation-informed perspective reveals how product attributes, clinical applications, end-user environments, and technology choices intersect to create differentiated demand pathways. Product type distinctions-spanning anesthesia machines, CPAP devices, nebulizers, oxygen concentrators, and ventilators-are foundational to this analysis, with subcategories such as portable versus stationary anesthesia machines and invasive versus noninvasive ventilator architectures dictating deployment scenarios and clinical training needs. Within CPAP platforms, the split between auto-adjusting and fixed-pressure systems creates divergent patient adherence profiles and service requirements, while nebulizer technologies such as jet, mesh, and ultrasonic variants carry distinct efficacy, maintenance, and consumable implications.

Application-based segmentation further refines insight by connecting device capabilities to clinical contexts; emergency and transport solutions demand ruggedized, rapidly deployable systems that prioritize battery longevity and ease of use, whereas intensive care units require ventilators and anesthesia systems with advanced modes tailored to adult, neonatal, and pediatric physiology. End-user segmentation across ambulatory surgical centers, clinics, home care settings, and hospitals highlights how procurement cycles, service contracts, and training investments vary by institutional maturity and operational complexity. Technology segmentation reiterates the invasive and noninvasive divide, underlining how mode-specific performance characteristics, including hybrid mode, pressure control, spontaneous mode, and volume control, influence clinician preference and regulatory pathways.

Patient age group classifications-adult, neonatal, and standard-intersect with mobility and power source segments, shaping product design priorities such as compactness, battery options, and ergonomics for caregivers. Distribution channel choices between direct sales, distributors, and online platforms compel manufacturers to align commercial models with buyer behavior and after-sales service expectations. Finally, pricing tier segmentation into economy, premium, and standard offerings drives positioning strategies, with premium devices emphasizing integrated analytics and service bundles while economy models focus on cost-effective reliability for resource-constrained settings. Together, these segmentation lenses enable more granular product prioritization, go-to-market planning, and lifecycle support strategies.

Regional divergence and converging imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific that shape commercialization and regulatory approaches

Regional dynamics exert a powerful influence on device design, reimbursement pathways, and distribution strategies, with distinct imperatives across the Americas, Europe Middle East & Africa, and Asia-Pacific regions. In the Americas, health systems place substantial emphasis on interoperability with electronic health record systems, robust aftermarket service networks, and evidence of clinical and economic value. This environment favors vendors that can demonstrate clinical outcomes and provide scalable service infrastructures to support hospitals and home care providers alike.

Europe, the Middle East & Africa present a heterogeneous landscape in which regulatory alignment with centralized European frameworks coexists alongside variable procurement models and health financing mechanisms across countries. Manufacturers operating in this geography must navigate harmonized device standards while adapting to local market access challenges and diverse clinical practice patterns. The need for adaptable service models and flexible pricing strategies is particularly acute in regions with mixed public and private provision.

Asia-Pacific is characterized by rapid adoption of portable and cost-efficient technologies, driven by expanding access to care, growing chronic disease prevalence, and investments in primary and community health capacity. Manufacturers targeting this region often prioritize scalable production, localized service partnerships, and product variants optimized for high-volume, resource-constrained settings. Across all regions, collaborations between global OEMs and regional distributors or contract manufacturers remain a central strategy to balance quality control, cost management, and market responsiveness.

Competitive corporate strategies that combine digital integration, service innovation, and modular product architectures to secure sustainable differentiation

Leading companies in the anesthesia and respiratory device space are aligning R&D investment, M&A activity, and service innovation to secure durable differentiation. Market leaders are accelerating integration of digital health features-algorithmic monitoring, remote diagnostics, and over-the-air software updates-into both stationary and portable platforms to enhance clinical decision support and reduce total cost of ownership through predictive maintenance. Strategic partnerships with software vendors, cloud platforms, and clinical research networks are becoming more common as firms seek to validate outcomes and demonstrate longitudinal value to health systems.

Corporate strategies increasingly emphasize service-led revenue streams, including managed service agreements, consumables contracts, and training-as-a-service offerings that deepen customer relationships and create recurring revenue. In parallel, product road maps show greater emphasis on modular architectures that allow OEMs to offer tiered configurations across economy, standard, and premium pricing tiers without regenerating entirely new hardware platforms.

Smaller innovators and niche players play a complementary role by advancing specific technologies such as low-cost mesh nebulizers, compact bilevel positive airway pressure systems, or neonatal-focused ventilator modes. These companies often attract partnerships with larger manufacturers seeking to broaden portfolios or accelerate time-to-market for new features. Across the competitive landscape, success favors firms that combine clinical validation, robust aftermarket support, and flexible commercial models that map to both institutional procurement cycles and patient-centric care pathways.

Actionable recommendations for product road maps, commercial models, and supply chain resilience to translate strategic insight into operational advantage

Industry leaders seeking to convert insight into advantage should prioritize a set of coordinated actions that address product, commercial, and operational dimensions. First, align product development with real-world clinical workflows by co-designing features with frontline clinicians and home-care providers, ensuring that device usability, maintenance protocols, and connectivity meet the demands of distributed care delivery. Second, invest in scalable service and training infrastructures that can be deployed across hospitals, ambulatory surgical centers, and home settings; this includes remote support platforms, certification programs for clinical staff, and standardized maintenance networks that reduce downtime and simplify procurement decisions.

Third, build supply chain flexibility by diversifying component sourcing, evaluating nearshoring opportunities, and developing contingency inventories for critical parts to reduce exposure to tariff and geopolitical shocks. Fourth, adopt commercial models that reflect buyer preferences across distribution channels, including direct sales for large health systems, distributor partnerships for regional reach, and online offerings for smaller purchasers and home users. Fifth, accelerate evidence generation through post-market surveillance, user experience studies, and real-world outcomes research to support regulatory filings, payer discussions, and purchasing committees.

Finally, prioritize cybersecurity and data governance early in product design to address emerging compliance requirements and protect patient data across connected devices. Collectively, these actions help firms reduce time-to-value for customers, build defensible revenue streams, and maintain operational resilience in a rapidly evolving clinical and regulatory environment.

A methodologically rigorous approach combining primary stakeholder engagement, regulatory review, and scenario analysis to ensure practical relevance and validation

The research methodology underpinning this analysis combines rigorous primary engagement with structured secondary analysis to ensure robustness and practical relevance. Primary research activities included in-depth interviews and structured conversations with clinical leaders across intensive care, operating room, and home care settings, procurement executives from hospitals and ambulatory surgical centers, and senior product and strategy leaders within device and distribution organizations. These interactions provided qualitative insight into clinical requirements, purchasing rationales, and the operational challenges associated with device deployment and maintenance.

Secondary research entailed systematic review of regulatory guidance documents, clinical practice guidelines, and peer-reviewed clinical literature that inform device design and modes of operation. Market intelligence was triangulated through a thorough assessment of product literature, technical specifications, and service offerings to validate claims and identify feature differentials across portfolios. Where appropriate, real-world device usage patterns and case studies were examined to understand performance under typical clinical and home-care conditions.

Analytical techniques included scenario planning to assess the operational impacts of tariff changes and supply chain disruptions, segmentation analysis to map product features to clinical contexts, and comparative benchmarking to evaluate aftermarket service models. Throughout the process, findings were validated through iterative stakeholder feedback to ensure accuracy, practical relevance, and applicability to strategic decision-making.

Synthesis of strategic imperatives and practical takeaways to guide investment priorities, commercial planning, and operational resilience in device portfolios

In summary, the anesthesia and respiratory device sector is undergoing a period of meaningful transformation driven by digital integration, decentralization of care, and a renewed focus on supply chain resilience. Device differentiation increasingly rests on the combination of clinical performance, software-enabled services, and flexible commercial models that serve hospitals, ambulatory centers, and home settings. Tariff changes and geopolitical dynamics are prompting re-evaluation of sourcing strategies and accelerating investments in regional capacity, while segmentation insights clarify the need for tailored product variants across modes, mobility profiles, patient age groups, and pricing tiers.

For stakeholders across the value chain-from manufacturers and distributors to clinical purchasing teams and health system strategists-the imperative is to adopt a holistic approach that integrates product development, service innovation, and operational agility. By doing so, organizations can better align offerings with clinician workflows, patient expectations, and evolving regulatory requirements. The conclusions drawn here provide a strategic framework for prioritizing investment, refining go-to-market approaches, and building resilient operations that are responsive to both near-term disruptions and longer-term shifts in how respiratory and anesthesia care is delivered.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Integration of artificial intelligence algorithms into ventilator control systems for predictive patient management
• 5.2. Expansion of non-invasive ventilation devices for home care and telemonitoring integration
• 5.3. Development of next-generation anesthesia machines with closed-loop drug delivery and real-time patient monitoring
• 5.4. Adoption of portable respiratory devices with wireless connectivity for remote patient management and data analytics
• 5.5. Emergence of single-use anesthesia circuits to reduce infection risk and improve operating room turnover efficiency
• 5.6. Implementation of advanced sensors in anesthesia workstations for early detection of patient hypoxia and hemodynamic instability
• 5.7. Surge in demand for high-flow nasal cannula therapy systems in critical care settings to support respiratory distress management
• 5.8. Rising incorporation of cloud-based ventilation data platforms for centralized monitoring and predictive maintenance
• 5.9. Advancements in ultrasonic nebulizer technology for targeted aerosol drug delivery in chronic respiratory disease management
• 5.10. Development of smart endotracheal tubes with embedded biosensors for continuous monitoring of airway pressures and biomarkers

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Anesthesia & Respiratory Devices Market, by Product Type

• 8.1. Anesthesia Machines
  • 8.1.1. Portable
  • 8.1.2. Stationary
• 8.2. Cpap Devices
  • 8.2.1. Auto Adjusting
  • 8.2.2. Fixed Pressure
• 8.3. Nebulizers
  • 8.3.1. Jet Nebulizer
  • 8.3.2. Mesh Nebulizer
  • 8.3.3. Ultrasonic Nebulizer
• 8.4. Oxygen Concentrators
  • 8.4.1. Portable
  • 8.4.2. Stationary
• 8.5. Ventilators
  • 8.5.1. Invasive
    • 8.5.1.1. Hybrid Mode
    • 8.5.1.2. Pressure Control
    • 8.5.1.3. Spontaneous Mode
    • 8.5.1.4. Volume Control
  • 8.5.2. Noninvasive
    • 8.5.2.1. Bilevel Positive Airway Pressure
    • 8.5.2.2. Continuous Positive Airway Pressure

9. Anesthesia & Respiratory Devices Market, by Application

• 9.1. Emergency And Transport
• 9.2. Home Care
• 9.3. Intensive Care
  • 9.3.1. Adult
  • 9.3.2. Neonatal
  • 9.3.3. Pediatric
• 9.4. Operating Room

10. Anesthesia & Respiratory Devices Market, by End User

• 10.1. Ambulatory Surgical Centers
• 10.2. Clinics
• 10.3. Home Care Settings
• 10.4. Hospitals

11. Anesthesia & Respiratory Devices Market, by Technology

• 11.1. Invasive
  • 11.1.1. Hybrid Mode
  • 11.1.2. Pressure Control
  • 11.1.3. Spontaneous Mode
  • 11.1.4. Volume Control
• 11.2. Noninvasive
  • 11.2.1. Bilevel Positive Airway Pressure
  • 11.2.2. Continuous Positive Airway Pressure

12. Anesthesia & Respiratory Devices Market, by Patient Age Group

• 12.1. Adult
• 12.2. Neonatal
• 12.3. Standard

13. Anesthesia & Respiratory Devices Market, by Mobility

• 13.1. Portable
• 13.2. Stationary

14. Anesthesia & Respiratory Devices Market, by Distribution Channel

• 14.1. Direct
• 14.2. Distributor
• 14.3. Online

15. Anesthesia & Respiratory Devices Market, by Power Source

• 15.1. Battery
• 15.2. Electric
• 15.3. Manual
• 15.4. Pneumatic

16. Anesthesia & Respiratory Devices Market, by Mode

• 16.1. Hybrid Mode
• 16.2. Pressure Control
• 16.3. Spontaneous Mode
• 16.4. Volume Control

17. Anesthesia & Respiratory Devices Market, by Pricing Tier

• 17.1. Economy
• 17.2. Premium
• 17.3. Standard

18. Anesthesia & Respiratory Devices Market, by Region

• 18.1. Americas
  • 18.1.1. North America
  • 18.1.2. Latin America
• 18.2. Europe, Middle East & Africa
  • 18.2.1. Europe
  • 18.2.2. Middle East
  • 18.2.3. Africa
• 18.3. Asia-Pacific

19. Anesthesia & Respiratory Devices Market, by Group

• 19.1. ASEAN
• 19.2. GCC
• 19.3. European Union
• 19.4. BRICS
• 19.5. G7
• 19.6. NATO

20. Anesthesia & Respiratory Devices Market, by Country

• 20.1. United States
• 20.2. Canada
• 20.3. Mexico
• 20.4. Brazil
• 20.5. United Kingdom
• 20.6. Germany
• 20.7. France
• 20.8. Russia
• 20.9. Italy
• 20.10. Spain
• 20.11. China
• 20.12. India
• 20.13. Japan
• 20.14. Australia
• 20.15. South Korea

21. Competitive Landscape

• 21.1. Market Share Analysis, 2024
• 21.2. FPNV Positioning Matrix, 2024
• 21.3. Competitive Analysis
  • 21.3.1. GE HealthCare Technologies Inc.
  • 21.3.2. Koninklijke Philips N.V.
  • 21.3.3. Dragerwerk AG & Co. KGaA
  • 21.3.4. Medtronic plc
  • 21.3.5. Fisher & Paykel Healthcare Corporation Limited
  • 21.3.6. Hamilton Medical AG
  • 21.3.7. Smiths Group plc
  • 21.3.8. Teleflex Incorporated
  • 21.3.9. B. Braun Melsungen AG
  • 21.3.10. ResMed Inc.

LIST OF FIGURES

• FIGURE 1. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2032 (%)
• FIGURE 3. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 4. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2032 (%)
• FIGURE 5. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2024 VS 2032 (%)
• FIGURE 7. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2032 (%)
• FIGURE 9. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2032 (%)
• FIGURE 11. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 12. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MOBILITY, 2024 VS 2032 (%)
• FIGURE 13. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MOBILITY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 14. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2032 (%)
• FIGURE 15. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 16. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY POWER SOURCE, 2024 VS 2032 (%)
• FIGURE 17. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY POWER SOURCE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 18. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2024 VS 2032 (%)
• FIGURE 19. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MODE, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 20. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRICING TIER, 2024 VS 2032 (%)
• FIGURE 21. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRICING TIER, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 22. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY REGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 23. AMERICAS ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 24. NORTH AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 25. LATIN AMERICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 26. EUROPE, MIDDLE EAST & AFRICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SUBREGION, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 27. EUROPE ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 28. MIDDLE EAST ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 29. AFRICA ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 30. ASIA-PACIFIC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 31. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY GROUP, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 32. ASEAN ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 33. GCC ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 34. EUROPEAN UNION ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 35. BRICS ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 36. G7 ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 37. NATO ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 38. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2032 (USD MILLION)
• FIGURE 39. ANESTHESIA & RESPIRATORY DEVICES MARKET SHARE, BY KEY PLAYER, 2024
• FIGURE 40. ANESTHESIA & RESPIRATORY DEVICES MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

• TABLE 1. ANESTHESIA & RESPIRATORY DEVICES MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
• TABLE 3. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, 2018-2024 (USD MILLION)
• TABLE 4. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, 2025-2032 (USD MILLION)
• TABLE 5. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2024 (USD MILLION)
• TABLE 6. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025-2032 (USD MILLION)
• TABLE 7. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, 2018-2024 (USD MILLION)
• TABLE 8. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, 2025-2032 (USD MILLION)
• TABLE 9. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 10. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 11. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 12. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 13. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 14. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ANESTHESIA MACHINES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 15. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 16. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 17. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 18. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 19. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 20. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 21. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 22. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 23. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 24. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 25. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 26. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 27. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, 2018-2024 (USD MILLION)
• TABLE 28. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, 2025-2032 (USD MILLION)
• TABLE 29. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, BY REGION, 2018-2024 (USD MILLION)
• TABLE 30. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, BY REGION, 2025-2032 (USD MILLION)
• TABLE 31. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 32. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 33. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 34. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CPAP DEVICES, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 35. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY AUTO ADJUSTING, BY REGION, 2018-2024 (USD MILLION)
• TABLE 36. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY AUTO ADJUSTING, BY REGION, 2025-2032 (USD MILLION)
• TABLE 37. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY AUTO ADJUSTING, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 38. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY AUTO ADJUSTING, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 39. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY AUTO ADJUSTING, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 40. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY AUTO ADJUSTING, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 41. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY FIXED PRESSURE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 42. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY FIXED PRESSURE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 43. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY FIXED PRESSURE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 44. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY FIXED PRESSURE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 45. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY FIXED PRESSURE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 46. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY FIXED PRESSURE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 47. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2018-2024 (USD MILLION)
• TABLE 48. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, 2025-2032 (USD MILLION)
• TABLE 49. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 50. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 51. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 52. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 53. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 54. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEBULIZERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 55. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 56. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 57. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 58. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 59. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 60. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY JET NEBULIZER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 61. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 62. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 63. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 64. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 65. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 66. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY MESH NEBULIZER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 67. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZER, BY REGION, 2018-2024 (USD MILLION)
• TABLE 68. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZER, BY REGION, 2025-2032 (USD MILLION)
• TABLE 69. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZER, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 70. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZER, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 71. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZER, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 72. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ULTRASONIC NEBULIZER, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 73. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2018-2024 (USD MILLION)
• TABLE 74. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, 2025-2032 (USD MILLION)
• TABLE 75. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 76. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 77. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 78. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 79. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 80. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OXYGEN CONCENTRATORS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 81. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 82. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 83. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 84. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 85. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 86. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PORTABLE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 87. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2018-2024 (USD MILLION)
• TABLE 88. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY REGION, 2025-2032 (USD MILLION)
• TABLE 89. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 90. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 91. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 92. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY STATIONARY, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 93. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, 2018-2024 (USD MILLION)
• TABLE 94. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, 2025-2032 (USD MILLION)
• TABLE 95. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 96. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 97. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 98. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 99. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 100. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VENTILATORS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 101. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
• TABLE 102. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, 2025-2032 (USD MILLION)
• TABLE 103. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 104. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 105. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 106. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 107. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 108. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 109. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HYBRID MODE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 110. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HYBRID MODE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 111. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HYBRID MODE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 112. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HYBRID MODE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 113. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HYBRID MODE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 114. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HYBRID MODE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 115. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 116. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 117. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 118. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 119. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 120. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 121. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SPONTANEOUS MODE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 122. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SPONTANEOUS MODE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 123. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SPONTANEOUS MODE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 124. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SPONTANEOUS MODE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 125. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SPONTANEOUS MODE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 126. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SPONTANEOUS MODE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 127. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 128. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 129. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 130. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 131. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 132. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 133. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, 2018-2024 (USD MILLION)
• TABLE 134. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, 2025-2032 (USD MILLION)
• TABLE 135. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 136. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 137. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 138. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 139. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 140. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 141. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY BILEVEL POSITIVE AIRWAY PRESSURE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 142. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY BILEVEL POSITIVE AIRWAY PRESSURE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 143. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY BILEVEL POSITIVE AIRWAY PRESSURE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 144. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY BILEVEL POSITIVE AIRWAY PRESSURE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 145. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY BILEVEL POSITIVE AIRWAY PRESSURE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 146. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY BILEVEL POSITIVE AIRWAY PRESSURE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 147. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 148. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 149. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 150. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 151. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 152. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 153. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2018-2024 (USD MILLION)
• TABLE 154. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY APPLICATION, 2025-2032 (USD MILLION)
• TABLE 155. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY AND TRANSPORT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 156. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY AND TRANSPORT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 157. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY AND TRANSPORT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 158. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY AND TRANSPORT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 159. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY AND TRANSPORT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 160. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY EMERGENCY AND TRANSPORT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 161. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 162. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOME CARE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 163. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOME CARE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 164. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOME CARE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 165. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 166. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOME CARE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 167. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INTENSIVE CARE, 2018-2024 (USD MILLION)
• TABLE 168. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INTENSIVE CARE, 2025-2032 (USD MILLION)
• TABLE 169. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INTENSIVE CARE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 170. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INTENSIVE CARE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 171. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INTENSIVE CARE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 172. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INTENSIVE CARE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 173. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INTENSIVE CARE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 174. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INTENSIVE CARE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 175. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 176. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ADULT, BY REGION, 2025-2032 (USD MILLION)
• TABLE 177. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ADULT, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 178. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ADULT, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 179. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ADULT, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 180. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ADULT, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 181. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEONATAL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 182. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEONATAL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 183. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEONATAL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 184. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEONATAL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 185. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEONATAL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 186. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NEONATAL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 187. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2018-2024 (USD MILLION)
• TABLE 188. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PEDIATRIC, BY REGION, 2025-2032 (USD MILLION)
• TABLE 189. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 190. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PEDIATRIC, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 191. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 192. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PEDIATRIC, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 193. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OPERATING ROOM, BY REGION, 2018-2024 (USD MILLION)
• TABLE 194. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OPERATING ROOM, BY REGION, 2025-2032 (USD MILLION)
• TABLE 195. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OPERATING ROOM, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 196. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OPERATING ROOM, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 197. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OPERATING ROOM, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 198. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY OPERATING ROOM, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 199. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2018-2024 (USD MILLION)
• TABLE 200. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY END USER, 2025-2032 (USD MILLION)
• TABLE 201. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 202. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 203. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 204. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 205. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 206. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 207. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 208. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CLINICS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 209. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 210. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CLINICS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 211. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 212. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CLINICS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 213. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 214. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 215. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 216. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 217. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 218. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 219. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2024 (USD MILLION)
• TABLE 220. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2025-2032 (USD MILLION)
• TABLE 221. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 222. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 223. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 224. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 225. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2018-2024 (USD MILLION)
• TABLE 226. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY TECHNOLOGY, 2025-2032 (USD MILLION)
• TABLE 227. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, 2018-2024 (USD MILLION)
• TABLE 228. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, 2025-2032 (USD MILLION)
• TABLE 229. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 230. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 231. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 232. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 233. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 234. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY INVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 235. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HYBRID MODE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 236. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HYBRID MODE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 237. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HYBRID MODE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 238. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HYBRID MODE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 239. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HYBRID MODE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 240. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY HYBRID MODE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 241. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 242. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 243. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 244. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 245. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 246. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PRESSURE CONTROL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 247. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SPONTANEOUS MODE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 248. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SPONTANEOUS MODE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 249. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SPONTANEOUS MODE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 250. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SPONTANEOUS MODE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 251. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SPONTANEOUS MODE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 252. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY SPONTANEOUS MODE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 253. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROL, BY REGION, 2018-2024 (USD MILLION)
• TABLE 254. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROL, BY REGION, 2025-2032 (USD MILLION)
• TABLE 255. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROL, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 256. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROL, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 257. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROL, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 258. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY VOLUME CONTROL, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 259. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, 2018-2024 (USD MILLION)
• TABLE 260. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, 2025-2032 (USD MILLION)
• TABLE 261. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 262. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 263. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 264. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 265. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 266. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY NONINVASIVE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 267. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY BILEVEL POSITIVE AIRWAY PRESSURE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 268. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY BILEVEL POSITIVE AIRWAY PRESSURE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 269. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY BILEVEL POSITIVE AIRWAY PRESSURE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 270. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY BILEVEL POSITIVE AIRWAY PRESSURE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 271. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY BILEVEL POSITIVE AIRWAY PRESSURE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 272. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY BILEVEL POSITIVE AIRWAY PRESSURE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 273. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE, BY REGION, 2018-2024 (USD MILLION)
• TABLE 274. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE, BY REGION, 2025-2032 (USD MILLION)
• TABLE 275. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE, BY GROUP, 2018-2024 (USD MILLION)
• TABLE 276. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE, BY GROUP, 2025-2032 (USD MILLION)
• TABLE 277. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE, BY COUNTRY, 2018-2024 (USD MILLION)
• TABLE 278. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY CONTINUOUS POSITIVE AIRWAY PRESSURE, BY COUNTRY, 2025-2032 (USD MILLION)
• TABLE 279. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2018-2024 (USD MILLION)
• TABLE 280. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY PATIENT AGE GROUP, 2025-2032 (USD MILLION)
• TABLE 281. GLOBAL ANESTHESIA & RESPIRATORY DEVICES MARKET SIZE, BY ADULT, BY REGION, 2018-2024 (USD MILLION)
• TABLE 282. GLOBAL ANESTHESIA & RESPIRATORY DEV